GIP and type 2 diabetes mellitus: With the discovery of GLP-1 and the demonstration that GLP-1, in contrast to GIP, is capable of restoring both beta and alpha cell responsiveness to glucose [7], it became apparent that therapies based on the actions of GLP-1 might be useful for T2DM.